858 Therapeutics · Domain Security

858 Therapeutics Domain Security

Domain security

Domain security posture for 858 Therapeutics, probed live across 1 host(s) and 1 registrable domain(s). 1 host(s) serve HTTPS (up to TLSv1.3); 0 advertise HSTS. Email/DNS controls: DNSSEC absent, SPF present, DMARC present (p=quarantine).

CompanyBiotechTherapeuticsOncologyPrecision MedicineDrug DiscoveryDNA Damage ResponseClinical StagePharmaceuticals

Transport & Host Security

8five8tx.com
HTTPS: yes · TLS: TLSv1.3 · HSTS: no · cert expires: Sep 6 20:27:52 2026 GMT

Domain (DNS/Email) Security

8five8tx.com
DNSSEC: no · SPF: yes · DMARC: yes (p=quarantine) · CAA: none

Source

Domain Security

858-therapeutics-domain-security.yml Raw ↑ 
generated: '2026-07-17'
method: probed
source: live DNS/TLS/HTTP probes of apis.yml + OpenAPI hosts
hosts:
- host: 8five8tx.com
  https: true
  tls_version: TLSv1.3
  cert_expires: Sep  6 20:27:52 2026 GMT
  hsts: false
domains:
- domain: 8five8tx.com
  dnssec: false
  caa: []
  spf: true
  dmarc: true
  dmarc_policy: quarantine